Mesenchymal contribution to early oesophageal tumour formation
Lead Research Organisation:
University of Cambridge
Department Name: Wellcome Trust - MRC Cam Stem Cell Inst
Abstract
Cancer is a deadly disease that forms and evolves as genetic alterations accumulate in our bodies. Constant exposure to our increasingly polluted environment leads to the accumulation of mutations in our DNA. These mutations alter the way our cells behave favouring cancer formation and disease progression.
Recent findings have suggested that mutations are not the sole cause of cancer and that other surrounding mutant-free cells, such as mesenchymal cells normally acting as supporting cells, also contribute to tumour formation from the earliest stages of the disease. Given that mesenchymal cells are thought to be more stable when compared to the ever-changing tumour cells, understanding the mechanisms by which they contribute to cancer formation and progression may represent an ideal opportunity to identify ways to intervene cancer in the clinic.
Despite this, very little is known as to how these supporting mesenchymal cells regulate tumour cell behaviour in the earliest stages of the disease, and the relevance of this cellular cross-talk for cancer progression. This project will use a recently characterised model of early tumour formation (Alcolea, Nat Cell Biol 2014; Frede, Nat Cell Biol, 2016). This model uses a cancer inducing agent found in cigarette smoke to induce discrete tumour lesions in the mouse oesophagus that can be detected from as early as 10 cells in size. Those are nascent tumours that can be visualized and analysed at a stage significantly earlier than those detected in the clinic, opening the possibility to understand the earliest stages of this devastating disease.
In the current proposal I set up to exploit this unique model system to understand how mesenchymal cells contribute to changes in tumour cells and their relevance for disease progression. To do that, I will use genetic tools to mark and visualize cells during the earliest stages of tumour formation. In addition, mechanisms regulating this process will be investigated by studying the molecular signatures of the different cell types, and validated by using a novel 3D ex vivo model designed to recapitulate in vivo tumour formation.
Recent findings have suggested that mutations are not the sole cause of cancer and that other surrounding mutant-free cells, such as mesenchymal cells normally acting as supporting cells, also contribute to tumour formation from the earliest stages of the disease. Given that mesenchymal cells are thought to be more stable when compared to the ever-changing tumour cells, understanding the mechanisms by which they contribute to cancer formation and progression may represent an ideal opportunity to identify ways to intervene cancer in the clinic.
Despite this, very little is known as to how these supporting mesenchymal cells regulate tumour cell behaviour in the earliest stages of the disease, and the relevance of this cellular cross-talk for cancer progression. This project will use a recently characterised model of early tumour formation (Alcolea, Nat Cell Biol 2014; Frede, Nat Cell Biol, 2016). This model uses a cancer inducing agent found in cigarette smoke to induce discrete tumour lesions in the mouse oesophagus that can be detected from as early as 10 cells in size. Those are nascent tumours that can be visualized and analysed at a stage significantly earlier than those detected in the clinic, opening the possibility to understand the earliest stages of this devastating disease.
In the current proposal I set up to exploit this unique model system to understand how mesenchymal cells contribute to changes in tumour cells and their relevance for disease progression. To do that, I will use genetic tools to mark and visualize cells during the earliest stages of tumour formation. In addition, mechanisms regulating this process will be investigated by studying the molecular signatures of the different cell types, and validated by using a novel 3D ex vivo model designed to recapitulate in vivo tumour formation.
Technical Summary
Cancer has traditionally been thought to form and evolve as genetic mutations accumulate, altering cell behaviour and ultimately leading to invasion and death. Recent findings have shown that the contribution of non-cell autonomous components, such as the tumour microenvironment, also play an essential role in the etiopathology of the disease. Mesenchymal fibroblasts, the main cellular component of the stroma in most cancers, have not only been involved in tumour initiation and progression, but have also shown potential prospects for cancer therapeutics. Despite this, very little is known as to how mesenchymal cells regulate epithelial cell behaviour in the earliest stages leading to tumour formation, and the relevance of this cross-talk for cancer progression. Using diethylnitrosamine, a nitrosamine found in cigarette smoke, I have recently developed a model of early tumorigenesis in the mouse oesophagus (Alcolea, Nat Cell Biol 2014). This model recapitulates the appearance of sporadic mutations that accumulate in human carcinogenesis, and creates discrete tumoral lesions identifiable as early as 10 cells in size. In the current proposal I set up to exploit this unique system to dissect epithelial and mesenchymal cross-talk in early neoplasia. To answer this question, I will combine my expertise in in vivo single cell lineage tracing together with transcriptional network analysis to investigate spatio-temporal changes in mesenchymal cell behaviour, and how these changes correlate with alterations in epithelial cell fate during tumour formation. Further mechanistic insights and potential therapeutic relevance will be gained by using an organotypic culture system specifically designed to recapitulate oesophageal cell behaviour ex vivo. Outputs from these studies will provide druggable targets to test their translational potential in preclinical models.
Planned Impact
Therapeutic approaches targeting cancer cells have often shown limited efficacy, with development of drug resistance and relapse. The aim of this proposal is to understand how tumour cells interact with their supporting neighbouring cells to determine their relevance for tumour formation and to identify alternative therapeutic strategies that may synergise and potentiate existing ones.
Who might benefit from this research?
The primary aim of this proposal is to benefit the patients and public health system. Pharmacological companies will also benefit from the potential identification of novel drug targets.
This work will advance our understanding in early tumour formation in squamous epithelial tissues such as the oesophagus. Of note, oesophageal models reveal lesions as early as 10 cells in size. Critically, by focussing on these early events we have the unique opportunity to better understand the complex cellular heterogeneity found in tumours, and the molecular networks driving disease progression. Identifying critical networks controlling cellular communication in these heterogeneous populations will ultimately provide a list of actionable targets of potential diagnostic or therapeutic value for the clinic.
How might they benefit from this research?
The proposed research will be focussed at understanding molecular networks involved in communication between tumour cells and mesenchymal cells, the major cellular component of the tumour supporting tissue. Validation of the relevance of targets for which drug inhibitors are available will be performed to produce a list of actionable targets, contributing towards drug target discovery. Most commercial companies use in vitro long passaged cell lines in their studies. This reveals little about the attributes of the cells in vivo, losing their dependence on environmental signals that are of critical relevance in an in vivo setting. One strength of this proposal is the use of an in vivo approach allowing the cellular communication networks to be explored in situ, i.e in the native environment.
Furthermore, we combine our in vivo approaches with a newly developed factor free 3D organotypic culture system that recapitulates the behaviour of epithelial cells in vitro. The peculiarity of this 3D system is that epithelial cells easily reconstruct the epithelial architecture without the need of exogenous matrixes, known to influence cell behaviour. It, therefore, constitutes a simple and cost effective protocol that lends itself to develop scalable and translatable assays to study human disease requiring minimal tissue input. This newly developed system ultimately offers a more physiological platform to test new drug targets, something that would reduce drug costs benefiting patients and the public health system.
Who might benefit from this research?
The primary aim of this proposal is to benefit the patients and public health system. Pharmacological companies will also benefit from the potential identification of novel drug targets.
This work will advance our understanding in early tumour formation in squamous epithelial tissues such as the oesophagus. Of note, oesophageal models reveal lesions as early as 10 cells in size. Critically, by focussing on these early events we have the unique opportunity to better understand the complex cellular heterogeneity found in tumours, and the molecular networks driving disease progression. Identifying critical networks controlling cellular communication in these heterogeneous populations will ultimately provide a list of actionable targets of potential diagnostic or therapeutic value for the clinic.
How might they benefit from this research?
The proposed research will be focussed at understanding molecular networks involved in communication between tumour cells and mesenchymal cells, the major cellular component of the tumour supporting tissue. Validation of the relevance of targets for which drug inhibitors are available will be performed to produce a list of actionable targets, contributing towards drug target discovery. Most commercial companies use in vitro long passaged cell lines in their studies. This reveals little about the attributes of the cells in vivo, losing their dependence on environmental signals that are of critical relevance in an in vivo setting. One strength of this proposal is the use of an in vivo approach allowing the cellular communication networks to be explored in situ, i.e in the native environment.
Furthermore, we combine our in vivo approaches with a newly developed factor free 3D organotypic culture system that recapitulates the behaviour of epithelial cells in vitro. The peculiarity of this 3D system is that epithelial cells easily reconstruct the epithelial architecture without the need of exogenous matrixes, known to influence cell behaviour. It, therefore, constitutes a simple and cost effective protocol that lends itself to develop scalable and translatable assays to study human disease requiring minimal tissue input. This newly developed system ultimately offers a more physiological platform to test new drug targets, something that would reduce drug costs benefiting patients and the public health system.
Publications
Chatzeli L
(2023)
A cellular hierarchy of Notch and Kras signaling controls cell fate specification in the developing mouse salivary gland
in Developmental Cell
Title | 3D Heterotypic cultures. |
Description | Briefly, pieces of intact squamous epithelial tissues (such as skin, oesophagus,...) can be exposed and grown over denuded ectopic stroma from the same or different origin (prepared as indicated in publication, https://www.biorxiv.org/content/10.1101/2021.02.19.431899v1), in order to study the cross-talk between different cellular compartments under control or disease conditions. A manuscript using this technology to study epithelial and stromal cross-talk in early oesophageal tumours (funded by MR/P019013/1) is currently under preparation . |
Type Of Material | Technology assay or reagent |
Year Produced | 2023 |
Provided To Others? | Yes |
Impact | This technology allows to perform functional studies to dissect epithelial-stromal cross-talk in 3D tissues under different pathological conditions, including early tumorigenesis. |
URL | https://www.biorxiv.org/content/10.1101/2021.02.19.431899v1 |
Title | Spatial single-cell RNA sequencing |
Description | As part of this project we explored the epithelial-stromal cross-talk during early tumour formation in the mouse oesophagus. In order to do this, we developed a spatial single-cell transcriptional technique. The aim was to isolate immediately adjacent epithelial and stromal cells in normal and tumour tissue to investigate cellular communication. This technique is based on single-cell laser capture microdissection (LCM) of frozen tissue sections. For this, we adapted LCM protocols in order to minimise alien RNA contamination and increase single-cell recovery yield. This initially proved successful with an acceptable 40% rate of spatially mapped single cell capture for early tumours. These positive results allowed us to proceed with the spatial microdissection of early tumours in order to perform our first spatial transcription analysis at single cell resolution. Unfortunately, unlike the tests performed, the tumour samples showed signs of RNA degradation due to an unforeseeable delay in the processing pipeline. We are planning on repeating this in the near future. In parallel, members of Prof. Julio Saez-Rodriguez (collaborator with ample expertise in network based analysis of proteomic and transcriptomic data) have adapted their network analytic pipeline for single cell RNAseq data considering our intellectual input. |
Type Of Material | Technology assay or reagent |
Year Produced | 2023 |
Provided To Others? | No |
Impact | Due to technical problems, we will have to repeat these experiments in the near future. |
Description | Early detection of Gastroesophageal cancer |
Organisation | Fundació Institut d'Investigació Sanitària Illes Balears |
Country | Spain |
Sector | Charity/Non Profit |
PI Contribution | This represents a collaboration in order to obtain human biopsies from patients screened for gastroesophageal cancer. This collaboration falls within the framework of our current research programme focused on investigating the molecular mechanisms underlying epithelial-mesenchymal crosstalk during the earliest events leading to oesophageal tumour formation using in vivo mouse models. These samples will allow us to validate observations made in our ongoing tumour mouse models, and will provide evidence for the clinical relevance of our observations. |
Collaborator Contribution | Our collaborators (Antònia Obrador, Esther Martinez Font, María José Bosque López, Pablo Luna, Alessandro Bianchi) a team, including a gastroenterologist, two surgeons, and basic scientists based at Son Espases Hospital (Spain), are creating a pipeline to collect and process oesophageal patient biopsied to be sent to our laboratory for further analysis. |
Impact | The collaboration is still ongoing. No outputs yet to be reported. |
Start Year | 2019 |
Description | Lineage tracing during early oesophageal tumour formation |
Organisation | Max Planck Society |
Department | Max Planck Institute for the Physics of Complex Systems |
Country | Germany |
Sector | Academic/University |
PI Contribution | We have generated a lineage tracing dataset of early tumours in the mouse oesophagus. For this mesenchymal cells have been genetically labelled with fluorescent reporters and fluorescent daughter cells have been quantified over time. This quantitative dataset will offer information on changes in mesenchymal cell behaviour at the earliest stages of tumour formation. |
Collaborator Contribution | Dr. Steffen Rulands is currently analysing the dataset to identify changes in mesenchymal cell behaviour during early tumour formation. |
Impact | This is a multi-disciplinary collaboration involving epithelial stem cell biologists and experts in applied mathematics and theoretical physics. The analysis is still ongoing. We anticipate that the by the end of this year we will obtain results needed for publication. |
Start Year | 2019 |
Description | Big Stem Cell Knit - Maite Bejar Serano |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Chat about CSCI research and answer public questions. |
Year(s) Of Engagement Activity | 2018 |
Description | Cambridge Beer Festival - Jamie McGinn |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Interactions and discussions with general public about stem cell research at 2017 Cambridge Beer Festival. |
Year(s) Of Engagement Activity | 2017 |
Description | Cambridge Fun Lab - Paula Jimenez Gomez |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Participation in a University of Cambridge-wide initiative in which departments, museums, libraries and other institutions welcome members of the public to free hands-on activities for all ages. |
Year(s) Of Engagement Activity | 2020 |
Description | Cambridge Science Festival, Cambridge Stem Cell Institute Beer Outreach Project Team - Jamie McGinn |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Raising public awareness at annual Cambridge Science Festival about a special collaboration between the Cambridge Stem Cell Institute and a local brewery to create and sell stem cell-themed beers. |
Year(s) Of Engagement Activity | 2019,2020 |
URL | http://www.moonshinebrewery.co.uk/regenerator.html |
Description | Ely Beer Festival - Jamie McGinn |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Interactions and discussions with general public about stem cell research at 2018 Ely Beer Festival. |
Year(s) Of Engagement Activity | 2018 |
Description | Instituto Maria Ibars, Denia (Alicante, Spain) - Paula Jimenez Gomez |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Virtual talk describing research at the Cambridge Stem Cell Institute following the international day of women and girls in science celebrations. |
Year(s) Of Engagement Activity | 2020 |
Description | Primary School Visits at Arbury Primary School, Cambridge - Maite Bejar Serano |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Schools |
Results and Impact | Work with groups of children (ages 10-11) to teach them about stem cells and differentiation. |
Year(s) Of Engagement Activity | 2018 |
Description | Pub Talk, The White Swan, Cambridge - Jamie McGinn |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Public discussion at pub regarding stem cell research. |
Year(s) Of Engagement Activity | 2017 |
Description | SciArt International Online Competition Judge - Jamie McGinn |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Selected art representing stem cell science for engagement with public. |
Year(s) Of Engagement Activity | 2018 |
Description | Stem Cell Institute both at Cambridge Science Festival - Maite Bejar Serano, Jamie McGinn, Paula Jimenez Gomez |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | Stem cell robot activity teaching about blood cell types and differentiation. Part of the 2017 iteration of the Cambridge Science Festival. |
Year(s) Of Engagement Activity | 2017 |
Description | Theory of Living Matter "General Meetings" Symposia Series - Adrien Hallou |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Organisation of an international and interdisciplinary symposia series. · November 2017 - 10th TLM General Meeting: "100th anniversary of Sir D'Arcy Thompson's On Growth and Form" Talk 1: Prof. L. Mahadevan (Harvard University, USA) "Morphogenesis: Geometry, Physics and Biology"; Talk 2: Prof. M. Akam (University of Cambridge), "Arthropod Segmentation: A case study in Evolutionary Developmental Biology". · April 2018 - 11th TLM General Meeting: "Developmental Dynamics: From Stem Cells to Organisms" Talk 1: Prof. O. Pourquié (Harvard University, USA) "Deconstructing the Segmentation Clock oscillator in vitro"; Talk 2: Prof. M. Stumpf (Imperial College London, UK) "Transition State Theory of Stem Cell Differentiation". · October 2018 - 12th TLM General Meeting: "Dynamics of spinal cord development" Joint Talk: Prof. J. Briscoe (Francis Crick Institute, UK) and Prof. K. Page (UCL, UK) "Dynamics of Spinal Cord Development: Theory & Experiments". · March 2019 - 13th TLM General Meeting: "Natural Cooperation" Talk: Prof. M. Nowak (Harvard University, USA) "Natural Cooperation". · July 2019 - 14th TLM General Meeting: "Epigenetics: Theory and experiments" Talk 1: Prof. W. Reik (Babraham Institute, UK) "Single cell epigenome landscape of development and ageing" Talk 2: Dr. S. Rulands (MPI PKS Dresden, Germany) "De-novo DNA methylation: a collective phenomenon". · March 2020 - 15th TLM General Meeting: "Quantitative approaches of live single cell transcriptomics" Talk 1: Prof. N. Papalopulu (Manchester University, UK) "Oscillations and noise shed new light in neural cell state transitions in vivo". Talk 2: Prof. J. Chubb (MRC LMCB, UK) "Transcriptional dynamics and cellular decision making" |
Year(s) Of Engagement Activity | 2017,2018,2019,2020 |
Description | Theory of Living Matter "Pub Talks" Seminar Series - Adrien Hallou |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Organisation of a "Pub Talks" seminar series open to the general public and taking place into two Cambridge popular Pubs The Panton Arms and the Old Bicycle Shop. · July 2017 - 8th TLM Pub Talk: Dr. J-B. Lugagne (University of Paris, France) "Real-time control of a genetic toggle switch". · January 2018 - 9th TLM Pub Talk: Dr. S. Prabakaran (University of Cambridge, UK) "Machine Learning for Genomics Data". · May 2018 - 10th TLM Pub Talk: Dr. L. Colwell (University of Cambridge, UK) "Using evolutionary sequence variation to build predictive models of protein structure and function" and Dr. C. Morgan (MRC LMB, UK) "Controlling Cellular Proteins via Protein Engineering: split protein engineering to unnatural amino acids". · July 2018 - 10th TLM Pub Talk: Dr. B. Verd (University of Oxford, UK) and Dr. E. Clark (Harvard University, USA) joint talk on "Expression dynamics and positional information during Drosophila segment patterning". · May 2019 - 11th TLM Pub Talk: Dr. R. Collepardo (University of Cambridge, UK) and Dr. S. Basu (University of Cambridge, UK) joint talk on "Visualising Genome Folding Dynamics - Theory & Experiments" · November 2019 - 12th TLM Pub Talk: Dr. A. Herrmann (University of Cambridge, UK) and Dr. Azizi (King's College London, UK) joint talk on "Interkinetic nuclear migration in retina - Theory & Experiments" |
Year(s) Of Engagement Activity | 2017,2018,2019 |
Description | Training session - Maite Bejar Serano |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Participated in training workshop that focussed on engaging with the public about animal research. |
Year(s) Of Engagement Activity | 2020 |